
The cover of our new paper in Nature Biomedical Engineering illustrates an inhalable virus-like-particle vaccine made of exosomes derived from lung cells and decorated with a recombinant SARS-CoV-2 receptor-binding domain.
The cover of our new paper in Nature Biomedical Engineering illustrates an inhalable virus-like-particle vaccine made of exosomes derived from lung cells and decorated with a recombinant SARS-CoV-2 receptor-binding domain.